{"product_id":"capmaxen-200mg-tablet-capmatinib","title":"Capmaxen 200mg tablet (capmatinib)","description":"\u003cp\u003e\u003cspan\u003eCapmaxen 200 mg is an oral targeted anticancer medicine manufactured by \u003c\/span\u003e\u003cstrong\u003eEverest Pharmaceuticals Ltd., Bangladesh\u003c\/strong\u003e\u003cspan\u003e. Each film-coated tablet contains \u003c\/span\u003e\u003cstrong\u003eCapmatinib 200 mg\u003c\/strong\u003e\u003cspan\u003e, a selective MET tyrosine kinase inhibitor. It is used for the treatment of adults with \u003c\/span\u003e\u003cstrong\u003emetastatic non-small-cell lung cancer (NSCLC)\u003c\/strong\u003e\u003cspan\u003e whose tumors have a mutation that leads to \u003c\/span\u003e\u003cstrong\u003eMET exon 14 skipping\u003c\/strong\u003e\u003cspan\u003e. Capmatinib works by blocking abnormal MET signaling, which can help slow the growth and spread of cancer cells. The recommended adult dose is \u003c\/span\u003e\u003cstrong\u003e400 mg twice daily\u003c\/strong\u003e\u003cspan\u003e, meaning two 200 mg tablets per dose, when prescribed according to the approved regimen. \u003c\/span\u003e\u003c\/p\u003e","brand":"XOMEDS","offers":[{"title":"Default Title","offer_id":45104547659819,"sku":null,"price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/Capmaxen.jpg?v=1787574872","url":"https:\/\/xomeds.com\/products\/capmaxen-200mg-tablet-capmatinib","provider":"XOMEDS","version":"1.0","type":"link"}